Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate effect on Sugammadex reversal of Rocuronium
NCT02932254Phase 4Completed
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Oct 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of magnesium sulfate in neuromuscular blockade (NMB) (2 arms), sponsored by Federal University of Rio de Janeiro. Primary endpoint: Train-of-Four Ratio at 3 hours. Started Oct 2016; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02932254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02932254.